Development and validation of a risk score to predict mortality during TB treatment in patients with TB-diabetes comorbidity.

ABSTRACT:

Background

Making an accurate prognosis for mortality during tuberculosis (TB) treatment in TB-diabetes (TB-DM) comorbid patients remains a challenge for health professionals, especially in low TB prevalent populations, due to the lack of a standardized prognostic model.

Methods

Using de-identified data from TB-DM patients from Texas, who received TB treatment had a treatment outcome of completed treatment or died before completion, reported to the National TB Surveillance System from January 2010-December 2016, we developed and internally validated a mortality scoring system, based on the regression coefficients.

Results

Of 1227 included TB-DM patients, 112 (9.1%) died during treatment. The score used nine characteristics routinely collected by most TB programs. Pati

SUBMITTER: Nguyen DT 

PROVIDER: S-EPMC6321653 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature